Fortress Biotech, Inc. (FBIO) › Operating IncomeFortress Biotech, Inc. (FBIO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$2.61M2010: -$9.24M2011: -$35.04M2012: -$27.18M2013: -$35.78M2014: -$20.65M2015: -$50.53M2016: -$65.71M2017: -$89.80M2018: -$120.00M2019: -$110.82M2020: -$94.27M2021: -$188.54M2022: -$203.56M2023: -$142.34M2024: -$110.38M2025: -$70.22M-$70.22M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$70.22M+36.4%2024-$110.38M+22.5%2023-$142.34M+30.1%2022-$203.56M-8.0%2021-$188.54M-100.0%2020-$94.27M+14.9%2019-$110.82M+7.6%2018-$120.00M-33.6%2017-$89.80M-36.7%2016-$65.71M-30.0%2015-$50.53M-144.7%2014-$20.65M+42.3%2013-$35.78M-31.7%2012-$27.18M+22.5%2011-$35.04M-279.2%2010-$9.24M-253.7%2009-$2.61M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share